Genscript Biotech(GNNSF)
$4.40+0.11 (+2.69%)
GNNSF
Genscript Biotech financials statements
$4.40
At close:+0.11 (+2.69%)
Genscript Biotech (GNNSF) Financial Statements
22 Followers
Genscript Biotech Financial Overview
Genscript Biotech's market cap is currently $9.80B. The company's EPS TTM is $-0.30; its P/E ratio is -14.09; and it has a dividend yield of 0.17%. Genscript Biotech is estimated to report earnings on March 24, 2027, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 959.53M | $ 594.49M | $ 560.48M | $ 625.70M | $ 490.10M |
| Gross Profit | $ 553.20M | $ 272.13M | $ 270.63M | $ 304.08M | $ 282.52M |
| Operating Income | $ 255.25M | $ 9.28M | $ 26.19M | $ -438.11M | $ -379.29M |
| EBITDA | $ 329.29M | $ 83.16M | $ 100.24M | $ -373.73M | $ -467.19M |
| Net Income | $ -532.83M | $ 2.96B | $ -95.48M | $ -226.85M | $ -358.71M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 843.01M | $ 621.18M | $ 1.93B | $ 1.46B | $ 1.41B |
| Total Assets | $ 4.85B | $ 5.28B | $ 3.39B | $ 2.55B | $ 2.23B |
| Total Debt | $ 258.84M | $ 723.74M | $ 416.99M | $ 349.80M | $ 156.45M |
| Net Debt | $ 116.35M | $ 591.75M | $ -1.03B | $ -674.20M | $ -1.02B |
| Total Liabilities | $ 876.30M | $ 954.91M | $ 1.34B | $ 1.18B | $ 846.17M |
| Stockholders' Equity | $ 3.96B | $ 4.32B | $ 1.39B | $ 1.01B | $ 1.05B |
| Cash Flow | |||||
| Free Cash Flow | $ 241.69M | $ -72.27M | $ -444.62M | $ -336.40M | $ -269.83M |
| Operating Cash Flow | $ 325.52M | $ 75.65M | $ -286.91M | $ -120.29M | $ -136.79M |
| Investing Cash Flow | $ -171.95M | $ -1.46B | $ -357.73M | $ -443.30M | $ -212.55M |
| Financing Cash Flow | $ -144.89M | $ 66.52M | $ 1.07B | $ 419.32M | $ 902.14M |
Currency in USD
